CLINICAL_TRIALS
trial_result
· 2012-11-09
Clinical Trial Update: Neonatal Erythropoietin in Asphyxiated Term Newborns [Phase 1]
Summary
A Phase 1 trial evaluating neonatal erythropoietin for term newborns with Hypoxic-ischemic Encephalopathy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Hypoxic-ischemic Encephalopathy | Phase 1 | Status: COMPLETED